Loading clinical trials...

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico | Clinical Trials | Clareo Health

COMPLETEDPhase 3

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Safety and Immunogenicity of a 3-Dose Schedule of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03630705•Sanofi Pasteur, a Sanofi Company

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Healthy Volunteers (Meningococcal Infection)

Interventions

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine

Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine

+6 more

Locations

11

Mexico

Locations (11)

Investigational Site Number :4840001

Acapulco de Juárez, Guerrero, Mexico

Investigational Site Number :4840002

Mexico City, Mexico City, Mexico

Investigational Site Number :4840003

Tlaltizapán, Morelos, Mexico

Investigational Site Number :6431018

Gatchina, Leningradskaya Oblast', Russia

Investigational Site Number :6431008

Krasnodar, Russia

Investigational Site Number :6431004

Perm, Russia

Key Dates

Start Date

October 17, 2018

Primary Completion Date

February 18, 2022

Completion Date

February 18, 2022

Last Updated

October 19, 2023

Related Studies

COMPLETEDPhase 3

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

NCT03869866

Healthy Volunteers (Meningococcal Infection)

COMPLETEDPhase 3

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

NCT03537508

Healthy Volunteers (Meningococcal Infection)

Sponsors

Lead Sponsor

Sanofi Pasteur, a Sanofi Company

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 19, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions